![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 22, 2021 11:47:17 AM
Secondly, Joe has been working on therapies for the treatment of HIV for ~40 years and has yet to produce anything with efficacy in the treatment of HIV or its symptoms. ITV-1 shows some promise to produce a small revenue stream, but that’s the culmination of ~40 years of research. You can go back and read / watch interviews with Charles from the 1990s and he’s talking about EXACTLY the same things he’s talking about now in the development of monoclonal antibodies. EXACTLY the same. In other words in 20+ years there has been no real advancement in their research.
It’s hilarious people think they’ve jumped into this company at the moment they’re about to skyrocket to a 3-digit stock, without any understanding of what this company actually is.
A fraud? Not in the sense that he’s trying to deceive intentionally. But a fraud in the sense that he is very good at finding sources of funding to keep the research going. Research that is over 40 years old at this point.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM